These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10309791)

  • 41. Cost-effectiveness analysis in relation to budgetary constraints and reallocative restrictions.
    Adang E; Voordijk L; Jan van der Wilt G; Ament A
    Health Policy; 2005 Oct; 74(2):146-56. PubMed ID: 16153475
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The context of health care policy: a social exchange approach to cost-effectiveness.
    Congdon DC
    J Health Soc Policy; 1989; 1(1):29-41. PubMed ID: 10313497
    [TBL] [Abstract][Full Text] [Related]  

  • 43. How do economic evaluations inform health policy decisions for treatment and prevention in Canada and the United States?
    Husereau D; Culyer AJ; Neumann P; Jacobs P
    Appl Health Econ Health Policy; 2015 Jun; 13(3):273-9. PubMed ID: 25316309
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cost-effectiveness and cost-benefit analysis.
    New England Regional Genetics Group
    Genetic Resour; 1998; 11(2):20-1. PubMed ID: 12817579
    [No Abstract]   [Full Text] [Related]  

  • 45. [Basic principles and methodological considerations of health economic evaluations].
    Loza C; Castillo-Portilla M; Rojas JL; Huayanay L
    Rev Peru Med Exp Salud Publica; 2011; 28(3):518-27. PubMed ID: 22086635
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The high cost of medicine: decision time.
    McKean WI
    N Z Med J; 1985 Jul; 98(782):545-8. PubMed ID: 3861967
    [No Abstract]   [Full Text] [Related]  

  • 47. The concept of cost in the economic evaluation of health care. A theoretical inquiry.
    Johannesson M
    Int J Technol Assess Health Care; 1994; 10(4):675-82. PubMed ID: 7843887
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analytic considerations in economic evaluations of multinational cardiovascular clinical trials.
    Torti FM; Reed SD; Schulman KA
    Value Health; 2006; 9(5):281-91. PubMed ID: 16961546
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Survey and examples of economic evaluation of health programmes in developing countries.
    Mills A
    World Health Stat Q; 1985; 38(4):402-31. PubMed ID: 3938111
    [No Abstract]   [Full Text] [Related]  

  • 50. [Evaluation and decision making. The economist's point of view (author's transl)].
    Griffiths A
    Rev Epidemiol Sante Publique; 1981; 29(3):363-70. PubMed ID: 6795692
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Health economic methods: cost-minimization, cost-effectiveness, cost-utility, and cost-benefit evaluations.
    Higgins AM; Harris AH
    Crit Care Clin; 2012 Jan; 28(1):11-24, v. PubMed ID: 22123096
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Methodological considerations in the analysis of cost effectiveness in dentistry.
    Antczak-Bouckoms AA; Tulloch JF; White BA; Capilouto EI
    J Public Health Dent; 1989; 49(4):215-22. PubMed ID: 2509689
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Economic evaluations in the Canadian Mental Health System. I: Theory behind economic evaluation.
    Fried BJ; Worthington C; Deber RB
    Can J Psychiatry; 1989 Oct; 34(7):633-6. PubMed ID: 2509061
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cost of illness studies: no aid to decision making: Reply to Shiell et al. (Health Policy, 8 (1987) 317-323).
    Behrens C; Henke K
    Health Policy; 1988 Oct; 10(2):137-41. PubMed ID: 10312717
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Economic evaluation of interventions in public health: potentials and limitations].
    Le Gales C; Triomphe A
    Rev Epidemiol Sante Publique; 1991; 39 Suppl 1():S15-29. PubMed ID: 1908111
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Standard or specific unit costs: Which criteria for choosing an economic evaluation of health strategies in multicentric studies?].
    Margier J; Baffert S; Le Corroller-Soriano AG;
    Rev Epidemiol Sante Publique; 2018 Mar; 66 Suppl 2():S93-S99. PubMed ID: 29526356
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treating AIDS: the economic issues.
    Drummond M; Davies L
    Health Policy; 1988 Aug; 10(1):1-19. PubMed ID: 10312592
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of economic evaluation in infection control.
    Saint S; Chenoweth C; Fendrick AM
    Am J Infect Control; 2001 Oct; 29(5):338-44. PubMed ID: 11584262
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cost-effectiveness analyses and their role in improving healthcare strategies.
    Rodriguez MI; Caughey AB
    Curr Opin Obstet Gynecol; 2013 Dec; 25(6):487-93. PubMed ID: 24126787
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Health economics, economic evaluation, and glaucoma.
    Kobelt G
    J Glaucoma; 2002 Dec; 11(6):531-9. PubMed ID: 12483101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.